|
1
|
Wu YM, Wang T, He Y, Song F, Wang Y, Zhu
L, Kong WM, Duan W and Zhang WY: Clinical management of cervical
intraepithelial neoplasia in pregnant and postpartum women. Arch
Gynecol Obstet. 289:1071–1077. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saslow D, Solomon D, Lawson HW, Killackey
M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur
DC, et al: American Cancer Society; American Society for Colposcopy
and Cervical Pathology; American Society for Clinical Pathology:
American Cancer Society, American Society for Colposcopy and
Cervical Pathology, and American Society for Clinical Pathology
screening guidelines for the prevention and early detection of
cervical cancer. Am J Clin Pathol. 137:516–542. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fader AN, Alward EK, Niederhauser A,
Chirico C, Lesnock JL, Zwiesler DJ, Guido RS, Lofgren DJ, Gold MA
and Moore KN: Cervical dysplasia in pregnancy: A
multi-institutional evaluation. Am J Obstet Gynecol. 203:113.e1–e6.
2010. View Article : Google Scholar
|
|
4
|
Insinga RP, Glass AG and Rush BB:
Diagnoses and outcomes in cervical cancer screening: A
population-based study. Am J Obstet Gynecol. 191:105–113. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morimura Y, Fujimori K, Soeda S, Hashimoto
T, Takano Y, Yamada H, Yanagida K and Sato A: Cervical cytology
during pregnancy-comparison with non-pregnant women and management
of pregnant women with abnormal cytology. Fukushima J Med Sci.
48:27–37. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Douvier S, Filipuzzi L and Sagot P:
Management of cervical intra-epithelial neoplasm during pregnancy.
Gynecol Obstet Fertil. 31:851–855. 2003.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frega A, Scirpa P, Corosu R, Verrico M,
Scarciglia ML, Primieri MR, Palazzo A, Iacovelli R and Moscarini M:
Clinical management and follow-up of squamous intraepithelial
cervical lesions during pregnancy and postpartum. Anticancer Res.
27:2743–2746. 2007.PubMed/NCBI
|
|
8
|
Wright TC Jr, Massad LS, Dunton CJ,
Spitzer M, Wilkinson EJ and Solomon D: 2006 ASCCP-Sponsored
Consensus Conference: 2006 consensus guidelines for the management
of women with abnormal cervical cancer screening tests. J Low Genit
Tract Dis. 11:201–222. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Duchrow M, Schlüter C, Key G, Kubbutat MH,
Wohlenberg C, Flad HD and Gerdes J: Cell proliferation-associated
nuclear antigen defined by antibody Ki-67: A new kind of cell
cycle-maintaining proteins. Arch Immunol Ther Exp (Warsz).
43:117–121. 1995.PubMed/NCBI
|
|
10
|
Scholzen T and Gerdes J: The Ki-67
protein: From the known and the unknown. J Cell Physiol.
182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tornesello ML, Buonaguro L, Rossi P Giorgi
and Buonaguro FM: Viral and cellular biomarkers in the diagnosis of
cervical Intraepithelial neoplasia and cancer. Biomed Res Int.
2013:5196192013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
von Knebel Doeberitz M: New molecular
tools for efficient screening of cervical cancer. Dis Markers.
17:123–128. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Palle C, Bangsbøll S and Andreasson B:
Cervical intraepithelial neoplasia in pregnancy. Acta Obstet
Gynecol Scand. 79:306–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vlahos G, Rodolakis A, Diakomanolis E,
Stefanidis K, Haidopoulos D, Abela K, Georgountzos V and Michalas
S: Conservative management of cervical intraepithelial neoplasia
(CIN (2–3)) in pregnant women. Gynecol Obstet Invest. 54:78–81.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yost NP, Santoso JT, Mcintire DD and Iliya
FA: Postpartum regression rates of antepartum cervical
intraepithelial neoplasia II and III lesions. Obstet Gynecol.
93:359–362. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sorosky JI: Cervical carcinoma
complicating pregnancy. Postgrad Obstet Gynecol. 15:1–6. 1995.
|
|
17
|
Kaplan KJ, Dainty LA, Dolinsky B, Rose GS,
Carlson J, McHale M and Elkas JC: Prognosis and recurrence risk for
patients with cervical squamous intraepithelial lesions diagnosed
during pregnancy. Cancer. 102:228–232. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zappacosta R, Colasante A, Viola P,
D'Antuono T, Lattanzio G, Capanna S, Gatta DM and Rosini S:
Chromogenic in situ hybridization and p16/Ki67 dual staining on
formalin-fixed paraffin-embedded cervical specimens: Correlation
with HPV-DNA test, E6/E7 mRNA test, and potential clinical
apllications. Biomed Res Int. 2013:4536062013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carozzi F, Confortini M, Palma P Dalla,
Del Mistro A, Gillio-Tos A, De Marco L, Giorgi-Rossi P, Pontenani
G, Rosso S, Sani C, et al: Use of p16-INK4A overexpression to
increase the specificity of human papillomavirus testing: A nested
substudy of the NTCC randomised controlled trial. Lancet Oncol.
9:937–945. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dray M, Russell P, Dalrymple C, Wallman N,
Angus G, Leong A, Carter J and Cheerala B: p16(INK4a) as a
complementary marker of high-grade intraepithelial lesions of the
uterine cervix. I: Experience with squamous lesions in 189
consecutive cervical biopsies. Pathology. 37:112–124. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mantovani F and Banks L: The human
papillomavirus E6 protein and its contribution to malignant
progression. Oncogene. 20:7874–7887. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Munger K, Basile JR, Duensing S, Eichten
A, Gonzalez SL, Grace M and Zacny VL: Biological activities and
molecular targets of the human papillomavirus E7 oncoprotein.
Oncogene. 20:7888–7898. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khleif SN, DeGregori J, Yee CL, Otterson
GA, Kaye FJ, Nevins JR and Howley PM: Inhibition of cyclin
D-CDK4/CDK6 activity is associated with an E2F-mediated induction
of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA.
93:4350–4354. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sano T, Oyama T, Kashiwabara K, Fukuda T
and Nakajima T: Expression status of p16 protein is associated with
human papillomavirus oncogenic potential in cervical and genital
lesions. Am J Pathol. 153:1741–1748. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klaes R, Friedrich T, Spitkovsky D, Ridder
R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D and von Knebel
Doeberitz M: Overexpression of p16(INK4A) as a specific marker for
dysplastic and neoplastic epithelial cells of the cervix uteri. Int
J Cancer. 92:276–284. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
von Knebel Doeberitz M, Rittmüller C, zur
Hausen H and Dürst M: Inhibition of tumorigenicity of cervical
cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int J
Cancer. 51:831–834. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kong CS, Balzer BL, Troxell ML, Patterson
BK and Longacre TA: p16INK4A immunohistochemistry is superior to
HPV in situ hybridization for the detection of high-risk HPV in
atypical squamous metaplasia. Am J Surg Pathol. 31:33–43. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Walts AE and Bose S: p16, Ki-67 and BD
ProExC immunostaining: A practical approach for diagnosis of
cervical intraepithelial neoplasia. Hum Pathol. 40:957–964. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pinto AP, Schlecht NF, Woo TY, Crum CP and
Cibas ES: Biomarker (ProEx C, p16INK4A, and MiB-1) distinction of
high-grade squamous intraepithelial lesion from its mimics. Mod
Pathol. 21:1067–1074. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Badr RE, Walts AE, Chung F and Bose S: BD
ProEx C: A sensitive and specific marker of HPV-associated squamous
lesions of the cervix. Am J Surg Pathol. 32:899–906. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi J, Liu H, Wilkerson M, Huang Y,
Meschter S, Dupree W, Schuerch C and Lin F: Evaluation of p16INK4a,
minichromosome maintenance protein 2, DNA topoisomerase IIalpha,
ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial
lesions. Hum Pathol. 38:1335–1344. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Branca M, Ciotti M, Santini D, Di Bonito
L, Giorgi C, Benedetto A, Paba P, Favalli C, Costa S, Agarossi A,
et al: p16(INK4A) expression is related to grade of CIN and
high-risk human papillomavirus but does not predict virus clearance
after conization or disease outcome. Int J Gynecol Pathol.
23:354–365. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Carreon JD, Sherman ME, Guillén D, Solomon
D, Herrero R, Jerónimo J, Wacholder S, Rodríguez AC, Morales J,
Hutchinson M, et al: CIN2 is a much less reproducible and less
valid diagnosis than CIN3: Results from a histological review of
population-based cervical samples. Int J Gynecol Pathol.
26:441–446. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Baak JP, Kruse AJ, Janssen E and van
Diermen B: Predictive testing of early CIN behaviour by molecular
biomarkers. Cell Oncol. 27:277–280. 2005.PubMed/NCBI
|
|
35
|
Roelens J, Reuschenbach M, von Knebel
Doeberitz M, Wentzensen N, Bergeron C and Arbyn M: p16INK4a
immunocytochemistry versus human papillomavirus testing for triage
of women with minor cytologic abnormalities: A systematic review
and meta-analysis. Cancer Cytopathol. 120:294–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Benevolo M, Terrenato I, Mottolese M,
Marandino F, Muti P, Carosi M, Rollo F, Ronchetti L, Mariani L,
Vocaturo G and Vocaturo A: Comparative evaluation of nm23 and p16
expression as biomarkers of high-risk human papillomavirus
infection and cervical intraepithelial neoplasia 2(+) lesions of
the uterine cervix. Histopathology. 57:580–586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pacchiarotti A, Ferrari F, Bellardini P,
Chini F, Collina G, Palma P Dalla, Ghiringhello B, Maccallini V,
Musolino F, Negri G, et al: Prognostic value of p16-INK4A protein
in women with negative or CIN1 histology result: A follow-up study.
Int J Cancer. 134:897–904. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sarian LO, Derchain SF, Yoshida A,
Vassallo J, Pignataro F and De Angelo Andrade LA: Expression of
cycloxygenase-2 (COX-2) and Ki67 as related to disease severity and
HPV detection in squamous lesions of the cervix. Gynecol Oncol.
102:537–541. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Calil LN, Edelweiss MI, Meurer L, Igansi
CN and Bozzetti MC: p16 INK4a and Ki67 expression in normal,
dysplastic and neoplastic uterine cervical epithelium and human
papillomavirus (HPV) infection. Pathol Res Pract. 210:482–487.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim J, Bagchi IC and Bagchi MK: Control of
ovulation in mice by progesterone receptor-regulated gene networks.
Mol Hum Reprod. 15:821–828. 2009. View Article : Google Scholar : PubMed/NCBI
|
